DJIA 17,959.44 154.64 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

58.96 -0.62 (-1.04%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $58.96 -1.04%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.12
Previous Close $59.58
Daily Range $58.55 - $59.56
52-Week Range $48.63 - $62.20
Market Cap $168.1B
P/E Ratio 32.38
Dividend (Yield) $1.80 (3.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 9,977,694
Average Daily Volume 10,274,525
Current FY EPS $3.49





Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary

Could Gilead Sciences, Inc. Be a Top Stock in 2015?

Gilead Sciences was a top stock this year, tacking on $44 billion in market value. But can we expect a repeat performance in 2015?

Cubist's Antibiotic Zerbaxa Wins FDA Nod for cUTI and cIAI - Analyst Blog

One Put, One Call Option To Know About for Merck & Co.

Dow Movers: CVX, INTC

Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results

NewLink Genetics Surges 3% Following Ebola Contract News

Could the Next Generation of Diabetes Treatments Be Found in This Illegal Drug?

Diabetes affects more than 29 million Americans and can lead to a number of serious complications. However, this currently illegal drug could provide a new pathway for diabetics to achieve better glycemic balance.

Exciting News: A Game-Changing Shingles Vaccine Could Be On Its Way

GlaxoSmithKline plc has reported impressive late stage trial results for its shingles vaccine.

Zoetis: Betting The Proverbial Farm?

Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst Blog

See More MRK News...

MRK's Top Competitors

MRK $58.96 (-1.04%)
Current stock: MRK
JNJ $106.74 (1.13%)
Current stock: JNJ
PFE $32.09 (0.47%)
Current stock: PFE
NVS $95.30 (0.73%)
Current stock: NVS